Artemis Medicare Services announced its Final Dividend . Check the Details here
Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the Promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. The specialty areas for AMSL include Orthopaedics, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. ASML has been awarded with the NABH and JCI accreditation. AMSL has also diversified its presence through Artemis Daffodil , Artemis Lite, Artemis Cardiac Care and Artemis Solace models.
Artemis Medicare Services Final Dividend
On June 15, 2024, the Board of Directors of the company announced the payment of the final dividend of Re. 0.45 per Equity Share of face value of Re. 1 each for the financial year
ended March 31, 2024. The Record Date for the Dividend is July 5, 2024 (Friday), while the shareholders will receive the payment of the dividend within 30 days from the record date.
Those Shareholders or their mandates:
whose names appear as Beneficial Owners as at the end of the business hours on Friday,July 5, 2024 in the list of Beneficial Owners to be furnished by National Securities
Depository Limited and Central Depository Services (India) Limited / whose names appear as Members in the Register of Members of the Company shall be eligible for the purpose of receipt of the Final dividend (i.e. those who wants to get the dividend must purchase the shares on/before 4th July, 2024 to get themselves resister in the record of the eligible receivers of the dividend.)
It is to be noted that on the record date the share price of the company may fall by the dividend amount i.e it may fall by Rs 0.45 in the opening session to adjust its price to ex-dividend.
So investors are adviced to make their decision wisely.
READ MORE : Godawari Power & Ispat announced a mega Buyback.Stock trading at its all time high!
Disclaimer:
The recommendations made above are by market analysts and are not advised by either the author, nor FinTrend 24. The author, nor the brokerage firm nor FinTrend 24 would be liable for any losses caused as a result of decisions based on this write-up. FinTrend 24 advises users to consult with certified experts before making any investment decision.